Globus Medical (GMED) Net Cash Flow Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Globus Medical | 10.79 Bn | 10.16 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.99% |
| Dec 31, 2025 | 71.54% |
| Sep 30, 2025 | 10.89% |
| Jun 30, 2025 | -193.94% |
| Mar 31, 2025 | -62.35% |
| Dec 31, 2024 | 41.30% |
| Sep 30, 2024 | 33.66% |
| Jun 30, 2024 | 44.21% |
| Mar 31, 2024 | -62.40% |
| Sep 30, 2023 | -28.09% |
| Jun 30, 2023 | 138.28% |
| Mar 31, 2023 | 325.88% |
| Dec 31, 2022 | -9.01% |
| Sep 30, 2022 | -93.38% |
| Jun 30, 2022 | -34.09% |
| Mar 31, 2022 | -1.39% |
| Dec 31, 2021 | -29.21% |
| Sep 30, 2021 | 105.19% |
| Jun 30, 2021 | 43.01% |
| Mar 31, 2021 | -35.49% |
| Dec 31, 2020 | -29.51% |
| Sep 30, 2020 | 57.03% |
| Jun 30, 2020 | 49.28% |
| Mar 31, 2020 | -31.74% |
| Dec 31, 2019 | 18.51% |
| Sep 30, 2019 | 8.29% |
| Jun 30, 2019 | -19.02% |
| Mar 31, 2019 | -21.63% |
| Sep 30, 2018 | 16.21% |
| Jun 30, 2018 | 15.20% |
| Mar 31, 2018 | 14.88% |
| Dec 31, 2017 | 9.67% |
| Sep 30, 2017 | -52.99% |
| Jun 30, 2017 | -36.54% |
| Mar 31, 2017 | 19.30% |
| Dec 31, 2016 | -37.79% |
| Sep 30, 2016 | -16.39% |